With more and more states, including now New York, legalizing adult use of cannabis, it seems out of touch that the major US stock exchanges continue to refuse listings to US-based plant-touching companies. In this post of ENTREPRENEURSHIP AND EMPOWERMENT David N. Feldman explains why their arguments for not doing so make no sense, and why these listings could be transformational for the rapidly growing industry.

David is a partner in the prominent boutique law firm of Hiller PC in New York. He is also CEO and co-founder of cannabis consulting firm Skip Intro Advisors LLC. His law practice focuses on corporate and securities matters and general representation of public and private companies, investment banks, private equity firms and high net worth individuals. He also actively advises on mergers and acquisitions and private equity, debt, venture capital and other financings. He has a strong focus on the cannabis industry and has received numerous recognitions and accolades for his work in the space.

Skip Intro advises emerging cannabis companies on strategic, financial, branding, technology and regulatory issues. Contact him at [email protected]. On Insta it’s @davidfeldman1000, on Clubhouse @David Feldman